Overview

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".
Phase:
Phase 2
Details
Lead Sponsor:
Mundipharma Research GmbH & Co KG
Treatments:
Naloxone
Oxycodone